We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Novel Mechanism for DNA Repair

By Biotechdaily staff writers
Posted on 29 May 2002
A new mechanism has been proposed for the repair of damaged DNA by mobile bits of DNA called long interspersed elements, or LINE-1s (L1s). More...
These make up about 17% of human DNA, but little is known about their role in cell metabolism.

A study published in the June 2002 issue of Nature Genetics provides new insights into the role of L1s in the repair of broken strands of DNA. This work is the result of a collaboration between researchers from the University of Michigan Medical School (Ann Arbor, USA) and Louisiana State University (Baton Rouge, USA).

It was previously known that L1s utilize reverse transcriptase to replicate themselves and an endonuclease to cut the genetic DNA and create a space, so they can insert themselves into the genome. "We knew about the endonuclease pathway,” says Tammy A. Morrish, first author of the paper. "But we did not know there was another mechanism that did not require endonuclease, or that L1s could jump into existing breaks in DNA.”

The current study describes a pathway for L1 retrotransposition in Chinese hamster ovary cells that acts independently of endonuclease but is dependent on reverse transcriptase. These findings suggest that L1s can integrate into lesions, resulting in retrotransposition-mediated DNA repair.

Future studies will examine whether it is possible to direct L1s to repair specific breaks in DNA, whether L1s can be used as vectors to deliver genetic material to specific DNA locations, and the impact of an L1 insertion on genes.




Related Links:
U. of Michigan
Louisiana State U.

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.